McKesson's High Stakes Gamble on Earnings Growth McKesson Corporation is set to release its Q1 2027 earnings on August 5th, amidst mounting expectations of continued growth. The company has a market cap of $93.
2 billion and operates through four segments: U. S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical Surgical Solutions, and International.
The mixed bag of results from McKesson's Q4 2026 earnings release – a revenue shortfall but an adjusted EPS that exceeded expectations – has analysts reassessing their forecasts.